CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Statement of Cash Flows [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 6,836	$ 8,558
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	5,863	4,418
Depreciation, Depletion and Amortization, Nonproduction	1,454	1,540
Share-based Compensation	140	151
Deferred Income Tax Expense (Benefit)	140	31
Gain (Loss) on Disposition of Business	(37)	(299)
Goodwill and Indefinite-lived Intangibles Impairment Charges	402	1,713
Changes in:
Increase (Decrease) in Accounts Receivable	(488)	(342)
Increase (Decrease) in Inventories	(386)	(506)
Increase (Decrease) in Accounts Payable and Accrued Liabilities	322	243
Increase (Decrease) in Other Operating Assets and Liabilities, Net	374	(164)
Other Noncash Income (Expense)	234	283
Net Cash Provided by (Used in) Operating Activities	8,018	7,068
Net Cash Provided by (Used in) Investing Activities [Abstract]
Capital expenditures	(1,223)	(1,642)
Proceeds from asset sales	80	3,648
Acquisitions, net of cash acquired	(186)	(112)
Payments to Acquire Short-term Investments	(762)	(2,106)
Proceeds from Sale of Short-term Investments	683	179
Change in investments	(31)	(836)
Net Cash Provided by (Used in) Investing Activities	(1,439)	(869)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Payments of Dividends	(3,733)	(3,614)
Proceeds from (Repayments of) Short-term Debt	2,020	352
Proceeds from (Repayments of) Other Long-term Debt	1,721	1,112
Repayments of Long-term Debt	(2,239)	(1,911)
Payments for Repurchase of Common Stock	(2,503)	(4,253)
Proceeds From Stock Options Exercised And Other Financing Activities	1,007	2,009
Net Cash Provided by (Used in) Financing Activities	(3,727)	(6,305)
Effect of Exchange Rate on Cash and Cash Equivalents	(285)	(248)
Cash and Cash Equivalents, Period Increase (Decrease)	2,567	(354)
Cash and Cash Equivalents, at Carrying Value	$ 9,403	$ 8,204